Drug Efficacy Prediction Using DDI Embeddings and Chemical Structure

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for predicting drug efficacy in treating diseases are error-prone and non-scalable, relying heavily on individual understanding of biochemical targets and chemical structures, and do not effectively utilize Drug-Drug Interaction (DDI) data for accurate predictions.

Innovation Solution

A system and method that utilizes DDI and Drug-Target Interaction (DTI) embedding values, combined with chemical structure data, to predict drug efficacy in treating medical conditions by training a machine-learning model with approved drug designations, enabling scalable and accurate predictions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current methods rely on chemical structure similarity and known DTI data to predict drug efficacy, then prediction can be performed, but the process is error-prone and non-scalable

Engineering Contradiction:
Improveprediction accuracyVSAvoidscalability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces manual biochemical target understanding and chemical structure analysis with an automated machine learning system. The ML model processes DDI embedding values and chemical structure data elements to predict efficacy, eliminating the need for individual expert interpretation and enabling scalable automation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces DDI embedding values as an intermediary representation that captures drug interaction patterns. This embedding space serves as a mediator between raw DDI data and the machine learning model, enabling the system to leverage complex interaction patterns without requiring direct manual analysis of each interaction.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If individual understanding of biochemical targets is used to analyze predicted effects, then efficacy determination can be made, but the process becomes non-scalable and error-prone

Engineering Contradiction:
Improveefficacy determination accuracyVSAvoidprediction throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent replaces manual biochemical analysis with automated machine learning inference. The trained ML model directly processes DDI embedding values and chemical structure data to output efficacy predictions, eliminating the need for individual expert interpretation and enabling high-throughput automated decision-making.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If DDI data is utilized to extract latent information, then prediction accuracy improves, but the system complexity increases

Engineering Contradiction:
Improveprediction accuracyVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts latent information from DDI data by computing DDI embedding values in a reduced-dimensional space. This embedding process captures essential interaction patterns while filtering out noise and redundancy, enabling the ML model to work with compressed representations that reduce computational complexity while maintaining predictive accuracy.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS20250329457A1System and method of predicting efficacy of treatment
Publication Date: 2025.10.23 BG NEGEV TECHNOLOGIES & APPLICATIONS LTD
  • US20250329457A1 patent drawing
  • US20250329457A1 patent drawing
  • US20250329457A1 patent drawing

AI summary

A system and method of predicting efficacy of treatment of a predetermined medical condition by at least one processor may include obtaining a Drug-Drug Interaction (DDI) embedding value, representing occurrence of DDIs between a substance of interest and one or more drugs selected from a plurality of baseline drugs, in a DDI embedding space; receiving a chemical structure data element, representing a chemical structure of the substance of interest; and predicting efficacy of the substance of interest in treatment of the predetermined medical condition based on (i) the DDI embedding value and (ii) the structure data element.